Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.


Journal

JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 28 3 2020
pubmed: 28 3 2020
medline: 31 10 2020
Statut: ppublish

Résumé

For patients with early-stage breast cancer, predicting the risk of metastatic relapse is of crucial importance. Existing predictive models rely on agnostic survival analysis statistical tools (eg, Cox regression). Here we define and evaluate the predictive ability of a mechanistic model for time to distant metastatic relapse. The data we used for our model consisted of 642 patients with 21 clinicopathologic variables. A mechanistic model was developed on the basis of two intrinsic mechanisms of metastatic progression: growth (parameter α) and dissemination (parameter μ). Population statistical distributions of the parameters were inferred using mixed-effects modeling. A random survival forest analysis was used to select a minimal set of five covariates with the best predictive power. These were further considered to individually predict the model parameters by using a backward selection approach. Predictive performances were compared with classic Cox regression and machine learning algorithms. The mechanistic model was able to accurately fit the data. Covariate analysis revealed statistically significant association of By providing informative estimates of the invisible metastatic burden at the time of diagnosis and forward simulations of metastatic growth, the proposed model could be used as a personalized prediction tool for routine management of patients with breast cancer.

Identifiants

pubmed: 32213092
doi: 10.1200/CCI.19.00133
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-274

Auteurs

Chiara Nicolò (C)

Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.
Institut de Mathématiques de Bordeaux, UMR 5251, CNRS, Bordeaux, France.

Cynthia Périer (C)

Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.
Institut de Mathématiques de Bordeaux, UMR 5251, CNRS, Bordeaux, France.

Melanie Prague (M)

Statistics in Systems Biology and Translational Medicine Team, Inria Bordeaux Sud-Ouest, University of Bordeaux, Bordeaux, France.
INSERM U1219, Bordeaux Public Health, University of Bordeaux, Bordeaux, France.

Carine Bellera (C)

INSERM U1219, Bordeaux Public Health, University of Bordeaux, Bordeaux, France.
Department of Clinical Epidemiology and Clinical Research, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux, France.

Gaëtan MacGrogan (G)

Department of Biopathology, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux, France.
INSERM U1218, Bordeaux Public Health, University of Bordeaux, Bordeaux, France.

Olivier Saut (O)

Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.
Institut de Mathématiques de Bordeaux, UMR 5251, CNRS, Bordeaux, France.

Sébastien Benzekry (S)

Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.
Institut de Mathématiques de Bordeaux, UMR 5251, CNRS, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH